Galectin Therapeutics (GALT) Profit After Tax Growth (1y) (2011 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | PAT Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,216,509.61 Bn | 1,216,509.61 Bn | - | 65.80% |
| 2 | Alterity Therapeutics | 764,224.41 Bn | 764,224.38 Bn | - | - |
| 3 | Legend Biotech | 2,716.00 Bn | 2,715.71 Bn | 242.10 Mn | 17.05% |
| 4 | Nanobiotix | 2,248.83 Bn | 2,248.77 Bn | - | - |
| 5 | Akari Therapeutics | 1,951.18 Bn | 1,951.17 Bn | - | -290.15% |
| 6 | Vertex Pharmaceuticals | 113.69 Bn | 106.44 Bn | 2.59 Bn | 59.59% |
| 7 | Evaxion A | 64.16 Bn | 64.14 Bn | - | -129.68% |
| 8 | Regeneron Pharmaceuticals | 63.94 Bn | 55.18 Bn | 3.31 Bn | -10.08% |
| 9 | Alnylam Pharmaceuticals | 40.13 Bn | 37.12 Bn | 959.66 Mn | 1,228.66% |
| 10 | Galectin Therapeutics | 165.77 Mn | 151.67 Mn | - | 47.61% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 47.61% |
| Dec 31, 2025 | 54.04% |
| Sep 30, 2025 | 27.06% |
| Jun 30, 2025 | 39.20% |
| Mar 31, 2025 | 16.17% |
| Dec 31, 2024 | -19.71% |
| Sep 30, 2024 | -7.59% |
| Jun 30, 2024 | -35.74% |
| Mar 31, 2024 | 0.33% |
| Dec 31, 2023 | 5.99% |
| Sep 30, 2023 | -21.30% |
| Jun 30, 2023 | 5.19% |
| Mar 31, 2023 | -16.06% |
| Dec 31, 2022 | -47.26% |
| Sep 30, 2022 | -0.90% |
| Jun 30, 2022 | -13.78% |
| Mar 31, 2022 | -56.71% |
| Dec 31, 2021 | 8.04% |
| Sep 30, 2021 | -43.36% |
| Jun 30, 2021 | -38.19% |
| Mar 31, 2021 | -78.23% |
| Dec 31, 2020 | -52.85% |
| Sep 30, 2020 | -113.47% |
| Jun 30, 2020 | -103.94% |
| Mar 31, 2020 | -49.73% |
| Dec 31, 2019 | -68.43% |
| Sep 30, 2019 | -1.16% |
| Jun 30, 2019 | 21.93% |
| Mar 31, 2019 | 44.22% |
| Dec 31, 2018 | -28.04% |
| Sep 30, 2018 | 37.57% |
| Jun 30, 2018 | 14.82% |
| Mar 31, 2018 | 13.75% |
| Dec 31, 2017 | 48.12% |
| Sep 30, 2017 | 2.61% |
| Jun 30, 2017 | 18.32% |
| Mar 31, 2017 | 27.40% |
| Dec 31, 2016 | 1.71% |
| Sep 30, 2016 | 23.12% |
| Jun 30, 2016 | -18.87% |
| Mar 31, 2016 | -40.90% |
| Dec 31, 2015 | -25.19% |
| Sep 30, 2015 | -67.34% |
| Jun 30, 2015 | -35.40% |
| Mar 31, 2015 | 5.56% |
| Dec 31, 2014 | -33.30% |
| Sep 30, 2014 | 0.68% |
| Jun 30, 2014 | -34.79% |
| Mar 31, 2014 | -59.54% |
| Dec 31, 2013 | -17.80% |
| Sep 30, 2013 | -31.72% |
| Jun 30, 2013 | 4.36% |
| Mar 31, 2013 | -64.26% |
| Dec 31, 2012 | 29.45% |
| Sep 30, 2012 | -32.59% |
| Jun 30, 2012 | 14.93% |
| Mar 31, 2012 | 18.48% |
| Dec 31, 2011 | -362.64% |
| Sep 30, 2011 | -82.87% |
| Jun 30, 2011 | -89.06% |